Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Barnidge

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Chemistry|October 3, 2015
Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow AspirationH Robert Bergen, Surendra Dasari, Angela Dispenzieri, et al.
Clinical Chemistry|December 22, 2009
Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variantsMary F Lopez, Taha Rezai, David A Sarracino, et al.
Clinical Chemistry|August 20, 2016
Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryJohn R Mills, Mindy C Kohlhagen, Surendra Dasari, et al.
Journal of Proteome Research|August 20, 2014
Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometryDavid R Barnidge, Surendra Dasari, Marina Ramirez-Alvarado, et al.
American Journal of Hematology|March 16, 2017
Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of conceptMarina Ramirez-Alvarado, David R Barnidge, David L Murray, et al.
Clinical Chemistry|August 13, 2016
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryMindy C Kohlhagen, David R Barnidge, John R Mills, et al.
Analytical Chemistry|May 27, 2016
Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated VasculitisJohn R Mills, Divi Cornec, Surendra Dasari, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
Clinical Chemistry|January 1, 2016
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based AssaysAndrew N Hoofnagle, Jeffrey R Whiteaker, Steven A Carr, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Chemistry|October 3, 2015
Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow AspirationH Robert Bergen, Surendra Dasari, Angela Dispenzieri, et al.
Clinical Chemistry|December 22, 2009
Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variantsMary F Lopez, Taha Rezai, David A Sarracino, et al.
Clinical Chemistry|August 20, 2016
Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryJohn R Mills, Mindy C Kohlhagen, Surendra Dasari, et al.
Journal of Proteome Research|August 20, 2014
Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometryDavid R Barnidge, Surendra Dasari, Marina Ramirez-Alvarado, et al.
American Journal of Hematology|March 16, 2017
Assessment of renal response with urinary exosomes in patients with AL amyloidosis: A proof of conceptMarina Ramirez-Alvarado, David R Barnidge, David L Murray, et al.
Clinical Chemistry|August 13, 2016
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass SpectrometryMindy C Kohlhagen, David R Barnidge, John R Mills, et al.
Analytical Chemistry|May 27, 2016
Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated VasculitisJohn R Mills, Divi Cornec, Surendra Dasari, et al.
Rheumatology (Oxford, England)|January 18, 2018
Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitisDivi Cornec, Brian F Kabat, John R Mills, et al.
Clinical Chemistry|January 1, 2016
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based AssaysAndrew N Hoofnagle, Jeffrey R Whiteaker, Steven A Carr, et al.
Pageof 4